Software Designed for Diagnostic Medical Image Viewing on Android Devices Receives US Approval
By MedImaging International staff writers Posted on 15 Apr 2013 |
Innovative new imaging software is making it possible for physicians to securely view patient images from a wide range of mobile devices and computers, collaborate with other clinicians, and generate high quality medical diagnosis from any location in real time.
Calgary Scientific, Inc. (Calgary, Canada) reported that it is providing mobile access to clinical data. Calgary Scientific is the first company to receive clearance from the United States (US) Food and Drug Administration (FDA) for their ResolutionMD software, to diagnose medical images on Android devices. This FDA clearance provides physicians with the flexibility to make a successful diagnosis very rapidly, using the popular Android platform.
“This is a huge step forward in making advanced mobile healthcare applications available on a broader range of devices,” said Alec J. Megibow, MD, MPH, FACR, president, Society of Abdominal Radiology (Houston, TX, USA). “We see the market now beginning to understand the importance of mobile viewing solutions, which are playing an increasingly critical role in helping practitioners deliver better patient care and opening creative ways to deliver high level interactive educational content.”
The software is very sensitive; patient data are never transferred or retained on the device, as is the case with other mobile device imaging software. A Mayo Clinic (Rochester, NY, USA) 2012 study showed that radiologists using ResolutionMD Mobile instead of a conventional picture archiving and communication system (PACS) workstation were able to access computed tomography (CT) scans of stroke victims 24% faster saving an average of 11 minutes per patient. This is an important achievement since stroke diagnosis as every second counts in making a difference toward patient recovery.
“We are excited to deliver this clearance to the institutions that rely on ResolutionMD to improve patient care,” said Pierre Lemire, president and CTO of Calgary Scientific. “This is also an important advancement for our valued partners as their custom branded solutions will be added under the Calgary Scientific registration with the FDA.”
Calgary Scientific is the first company to receive FDA clearance for diagnostic image viewing on a variety of Android devices, including the highly popular Samsung Galaxy tab. “Our extensive validation process which involves both lab testing as well as comparative reads was built on the protocol we established with the FDA when we first obtained clearance for ResolutionMD Mobile on iOS,” said Kyle Peterson, director, Regulatory and Corporate Affairs of Calgary Scientific. ResolutionMD is also CE marked for distribution in Europe and licensed by Health Canada.
Calgary Scientific is a global leader in providing sophisticated medical imaging software and collaboration solutions, as well as web, mobility, and collaboration enablement technologies to industries looking for secure access to their data or graphics intensive applications.
Related Links:
Calgary Scientific
Calgary Scientific, Inc. (Calgary, Canada) reported that it is providing mobile access to clinical data. Calgary Scientific is the first company to receive clearance from the United States (US) Food and Drug Administration (FDA) for their ResolutionMD software, to diagnose medical images on Android devices. This FDA clearance provides physicians with the flexibility to make a successful diagnosis very rapidly, using the popular Android platform.
“This is a huge step forward in making advanced mobile healthcare applications available on a broader range of devices,” said Alec J. Megibow, MD, MPH, FACR, president, Society of Abdominal Radiology (Houston, TX, USA). “We see the market now beginning to understand the importance of mobile viewing solutions, which are playing an increasingly critical role in helping practitioners deliver better patient care and opening creative ways to deliver high level interactive educational content.”
The software is very sensitive; patient data are never transferred or retained on the device, as is the case with other mobile device imaging software. A Mayo Clinic (Rochester, NY, USA) 2012 study showed that radiologists using ResolutionMD Mobile instead of a conventional picture archiving and communication system (PACS) workstation were able to access computed tomography (CT) scans of stroke victims 24% faster saving an average of 11 minutes per patient. This is an important achievement since stroke diagnosis as every second counts in making a difference toward patient recovery.
“We are excited to deliver this clearance to the institutions that rely on ResolutionMD to improve patient care,” said Pierre Lemire, president and CTO of Calgary Scientific. “This is also an important advancement for our valued partners as their custom branded solutions will be added under the Calgary Scientific registration with the FDA.”
Calgary Scientific is the first company to receive FDA clearance for diagnostic image viewing on a variety of Android devices, including the highly popular Samsung Galaxy tab. “Our extensive validation process which involves both lab testing as well as comparative reads was built on the protocol we established with the FDA when we first obtained clearance for ResolutionMD Mobile on iOS,” said Kyle Peterson, director, Regulatory and Corporate Affairs of Calgary Scientific. ResolutionMD is also CE marked for distribution in Europe and licensed by Health Canada.
Calgary Scientific is a global leader in providing sophisticated medical imaging software and collaboration solutions, as well as web, mobility, and collaboration enablement technologies to industries looking for secure access to their data or graphics intensive applications.
Related Links:
Calgary Scientific
Latest Imaging IT News
- New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
- Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
- AI-Based Mammography Triage Software Helps Dramatically Improve Interpretation Process
- Artificial Intelligence (AI) Program Accurately Predicts Lung Cancer Risk from CT Images
- Image Management Platform Streamlines Treatment Plans
- AI-Based Technology for Ultrasound Image Analysis Receives FDA Approval
- AI Technology for Detecting Breast Cancer Receives CE Mark Approval
- Digital Pathology Software Improves Workflow Efficiency
- Patient-Centric Portal Facilitates Direct Imaging Access
- New Workstation Supports Customer-Driven Imaging Workflow
Channels
Radiography
view channel
World's Largest Class Single Crystal Diamond Radiation Detector Opens New Possibilities for Diagnostic Imaging
Diamonds possess ideal physical properties for radiation detection, such as exceptional thermal and chemical stability along with a quick response time. Made of carbon with an atomic number of six, diamonds... Read more
AI-Powered Imaging Technique Shows Promise in Evaluating Patients for PCI
Percutaneous coronary intervention (PCI), also known as coronary angioplasty, is a minimally invasive procedure where small metal tubes called stents are inserted into partially blocked coronary arteries... Read moreMRI
view channel
AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans
Multiple sclerosis (MS) is a condition in which the immune system attacks the brain and spinal cord, leading to impairments in movement, sensation, and cognition. Magnetic Resonance Imaging (MRI) markers... Read more
Ultra-Powerful MRI Scans Enable Life-Changing Surgery in Treatment-Resistant Epileptic Patients
Approximately 360,000 individuals in the UK suffer from focal epilepsy, a condition in which seizures spread from one part of the brain. Around a third of these patients experience persistent seizures... Read more
AI-Powered MRI Technology Improves Parkinson’s Diagnoses
Current research shows that the accuracy of diagnosing Parkinson’s disease typically ranges from 55% to 78% within the first five years of assessment. This is partly due to the similarities shared by Parkinson’s... Read more
Biparametric MRI Combined with AI Enhances Detection of Clinically Significant Prostate Cancer
Artificial intelligence (AI) technologies are transforming the way medical images are analyzed, offering unprecedented capabilities in quantitatively extracting features that go beyond traditional visual... Read moreUltrasound
view channel
AI Identifies Heart Valve Disease from Common Imaging Test
Tricuspid regurgitation is a condition where the heart's tricuspid valve does not close completely during contraction, leading to backward blood flow, which can result in heart failure. A new artificial... Read more
Novel Imaging Method Enables Early Diagnosis and Treatment Monitoring of Type 2 Diabetes
Type 2 diabetes is recognized as an autoimmune inflammatory disease, where chronic inflammation leads to alterations in pancreatic islet microvasculature, a key factor in β-cell dysfunction.... Read moreNuclear Medicine
view channel
Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
COX-2, an enzyme that plays a key role in brain inflammation, can be significantly upregulated by inflammatory stimuli and neuroexcitation. Researchers suggest that COX-2 density in the brain could serve... Read more
Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC), which represents 15-20% of all breast cancer cases, is one of the most aggressive subtypes, with a five-year survival rate of about 40%. Due to its significant heterogeneity... Read moreGeneral/Advanced Imaging
view channel
AI-Powered Imaging System Improves Lung Cancer Diagnosis
Given the need to detect lung cancer at earlier stages, there is an increasing need for a definitive diagnostic pathway for patients with suspicious pulmonary nodules. However, obtaining tissue samples... Read more
AI Model Significantly Enhances Low-Dose CT Capabilities
Lung cancer remains one of the most challenging diseases, making early diagnosis vital for effective treatment. Fortunately, advancements in artificial intelligence (AI) are revolutionizing lung cancer... Read moreIndustry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more